Page 18 - Read Online

Veilleux et al. Mini-invasive Surg 2020;4:4 Mini-invasive Surgery
DOI: 10.20517/2574-1225.2020.01

Editorial Open Access

Metabolic and bariatric surgery: diabetes - a decade
of discovery

Eric Veilleux, Rami Lutfi

Department of Metabolic and Bariatric Surgery, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
Correspondence to: Dr. Eric Veilleux, Department of Metabolic and Bariatric Surgery, Advocate Illinois Masonic Medical Center,
3000 N Halsted St. Suite 703, Chicago, IL 60657, USA. E-mail: eveilleux86@gmail.com

How to cite this article: Veilleux E, Lutfi R. Metabolic and bariatric surgery: diabetes - a decade of discovery. Mini-invasive Surg
2020;4:4. http://dx.doi.org/10.20517/2574-1225.2020.01

Received: 1 Jan 2020 Accepted: 13 Jan 2020 Published: 20 Jan 2020
Science Editor: Daniel B. Jones Copy Editor: Jing-Wen Zhang Production Editor: Jing Yu

INTRODUCTION
Diabetes is a progressive and chronic condition that affects a growing percentage of the population each
year. Obesity is considered to be the central risk factor in the development of type 2 diabetes mellitus
(T2DM) in adults. In 2019, the top three countries for diabetes prevalence were found to be China, India,
[1,2]
and the United States, affecting 116, 77, and 31 million adults, respectively . More than 420 million adults
are affected worldwide, representing a significant burden to healthcare systems as well as the wellbeing of
[3]
the global population .

Metabolic and Bariatric surgery for the treatment of T2DM has been of significant interest in recent years.
At the start of the decade (2011), the International Diabetes Federation wrote a consensus statement
[4]
promoting the use of bariatric surgery in obese patients with poorly controlled diabetes . However, as the
number of adults with T2DM worldwide grows exponentially each year, metabolic and bariatric surgery
for treatment remains a topic of substantial interest. In 2019, the American Society for Metabolic and
Bariatric Surgery (ASMBS) held its annual Obesity Week Conference, electing diabetes as the central topic.
The presidential address (Eric J. DeMaria, MD Fellow of the American Society of Metabolic and Bariatric
Surgery) at this meeting highlighted a growing effort to raise awareness on the beneficial effects of surgery
for glycemic control. Dr. DeMaria suggested increasingly referring to metabolic surgery with patients
as “diabetes surgery” in order to promote the concept in the general population. As we continue to raise
awareness of the benefits of metabolic and bariatric surgery to those in the healthcare field as well as the
general population, it is important to evaluate what we have learned and what has yet to be discovered.

© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made.

www.misjournal.net